Literature DB >> 12543275

Molecular manipulation of neural precursors in situ: induction of adult cortical neurogenesis.

Paola Arlotta1, Sanjay S Magavi, Jeffrey D Macklis.   

Abstract

Over the past three decades, research exploring potential neuronal replacement therapies have focused on replacing lost neurons by transplanting cells or grafting tissue into diseased regions of the brain. Over most of the past century of modern neuroscience, it was thought that the adult brain was completely incapable of generating new neurons. However, in the last decade, the development of new techniques has resulted in an explosion of new research showing that neurogenesis, the birth of new neurons, normally occurs in two limited and specific regions of the adult mammalian brain, and that there are significant numbers of multipotent neural precursors in many parts of the adult mammalian brain. Recent findings from our lab demonstrate that it is possible to induce neurogenesis de novo in the adult mammalian brain, particularly in the neocortex where it does not normally occur, and that it may become possible to manipulate endogenous multipotent precursors in situ to replace lost or damaged neurons. Recruitment of new neurons can be induced in a region-specific, layer-specific, and neuronal type-specific manner, and newly recruited neurons can form long-distance connections to appropriate targets. Elucidation of the relevant molecular controls may both allow control over transplanted precursor cells and potentially allow the development of neuronal replacement therapies for neurodegenerative disease and other CNS injuries that do not require transplantation of exogenous cells.

Entities:  

Mesh:

Year:  2003        PMID: 12543275     DOI: 10.1016/s0531-5565(02)00156-0

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

Review 1.  Neurogenesis and brain injury: managing a renewable resource for repair.

Authors:  Anna F Hallbergson; Carmen Gnatenco; Daniel A Peterson
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus.

Authors:  Martin H Maurer; Robert E Feldmann; Carsten D Fütterer; Jo Butlin; Wolfgang Kuschinsky
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  Huntington's disease and neurogenesis: FGF-2 to the rescue?

Authors:  Albert R La Spada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 4.  Dynamics of CNS barriers: evolution, differentiation, and modulation.

Authors:  N Joan Abbott
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 5.  Can endocrine disruptors influence neuroplasticity in the aging brain?

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2007-02-04       Impact factor: 4.294

6.  Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice.

Authors:  Ye Xiong; Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2007-10-31       Impact factor: 3.252

7.  Granule cell dispersion and aberrant neurogenesis in the adult hippocampus of an LIS1 mutant mouse.

Authors:  Yanling Wang; Scott C Baraban
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

8.  Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.

Authors:  Ye Xiong; Dunyue Lu; Changsheng Qu; Anton Goussev; Timothy Schallert; Asim Mahmood; Michael Chopp
Journal:  J Neurosurg       Date:  2008-09       Impact factor: 5.115

9.  Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke.

Authors:  Xue-mei Zhang; Fang Du; Dan Yang; Chun-jiang Yu; Xiang-nan Huang; Wei Liu; Jin Fu
Journal:  BMC Neurosci       Date:  2010-10-25       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.